✦ New CED Clinical Relevance #80High Clinical Relevance Strong evidence or policy relevance with direct clinical implications. ⚒ Cannabis News | CED Clinic Parkinson'S DiseaseCell TherapyNeurodegenerationMotor SymptomsClinical Trials Why This MattersEarly-stage cell therapy trials in Parkinson's...
Survey of 47 Trials Maps Cannabinoid Research in Neurology—But Evidence Gaps Remain Large
The review highlights the broad therapeutic potential of cannabinoids in neurology, with promising results in symptom management for conditions like Multiple Sclerosis and Fibromyalgia. However, the lack of standardized study protocols, dosing, and outcome measures presents challenges for broader clinical implementation.
Survey of Cannabinoid Trials in Neurology: Promising but Unstandardized
The review highlights the broad therapeutic potential of cannabinoids in neurology, with promising results in symptom management for conditions like Multiple Sclerosis and Fibromyalgia. However, the lack of standardized study protocols, dosing, and outcome measures presents challenges for broader clinical implementation.
Radical Revelations: The Interplay of Nitrosative Stress, the Endocannabinoid System, and Treatment of Age-Related Disorders.
The crosstalk between the endocannabinoid system (ECS) and reactive nitrogen species (RNS) has emerged as an important area of investigation in recent years….
New funding to support SER-252 trial in advanced Parkinson’s
✦ New CED Clinical Relevance #80High Clinical Relevance Strong evidence or policy relevance with direct clinical implications. ⚒ Cannabis News | CED Clinic Parkinson'S DiseaseMovement DisordersSynthetic CannabinoidsDyskinesiaClinical Trials Why This MattersNovel cannabinoid therapeutics targeting specific Parkinson's...
Mapping the Clinical Trial Landscape for Cannabinoids in Neurology: A Registry-Based Systematic Review
The review highlights the broad therapeutic potential of cannabinoids in neurology, with promising results in symptom management for conditions like Multiple Sclerosis and Fibromyalgia. However, the lack of standardized study protocols, dosing, and outcome measures presents challenges for broader clinical implementation.
Pirepemat shows promise in trial for reducing risk of falls in Parkinson’s
✦ New CED Clinical Relevance #80High Clinical Relevance Strong evidence or policy relevance with direct clinical implications. ⚒ Cannabis News | CED Clinic Parkinson'S DiseaseFall PreventionMotor SymptomsNovel TherapeuticsSafety Why This MattersFalls represent one of the most...
Acupuncture May Ease Non-Motor Parkinson’s Symptoms, but Evidence Remains Uncertain
The results of the analysis suggested that acupuncture treatment could ameliorate the symptoms of depression, quality of life, cognition, total mentation, behaviour and mood, and activities of daily living in PD patients. Nevertheless, more prospective, well-designed RCTs with larger sample sizes are required to confirm our findings.
When it comes to Parkinson’s, hope is not a plan, but urgent action is
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Parkinson'S DiseaseNeurodegenerationPatient ExpectationsEvidence-Based MedicineChronic Disease Management Why This MattersParkinson's disease affects over 1 million...
Cannabinoids and cognition in Parkinson’s disease: Insights from animal models and emerging clinical evidence.
Parkinson’s disease (PD) is a progressive, multisystem neurodegenerative disorder characterized not only by motor impairments but also by a broad spectrum of…